Laurent Lévy
Chief Executive Officer en NANOBIOTIX .
Fortuna: 7 M $ al 31/03/2024
Origen de la red de primer grado Laurent Lévy.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
30
| Public Company | Medical Specialties | 30 |
12
| Public Company | Biotechnology | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Laurent Lévy a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
University of Maryland | College/University | Undergraduate Degree | |
University of Leiden | College/University | Graduate Degree | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Masters Business Admin | |
EM Lyon Business School | College/University | Undergraduate Degree | |
ESSEC Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
École Normale Supérieure | College/University | Doctorate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree Corporate Officer/Principal | |
Arthur Andersen & Cia
Arthur Andersen & Cia Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen & Cia is a French company. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National University of Cordoba | College/University | Doctorate Degree | |
Université Paris II Panthéon Assas | College/University | Graduate Degree | |
Biofortis SA
Biofortis SA Miscellaneous Commercial ServicesCommercial Services Biofortis SA operates as a contract research company in the field of human nutrition. The firm's laboratory allows exploration in the fields of metabolic disorders, bone mineralization, oxidative stress, inflammatory markers, lipids and lipoproteins, satiety hormones and mediators. The company was founded by Murielle Cazaubiel in 2002 and is headquartered in Saint Herblain, France. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Capgemini Consulting SAS
Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Olin Business School | College/University | Masters Business Admin | |
Chiron Therapeutics, Inc. | Corporate Officer/Principal | ||
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Institut Supérieur de Gestion | College/University | Graduate Degree | |
Gustave Roussy Foundation
Gustave Roussy Foundation Hospital/Nursing ManagementHealth Services Gustave Roussy Foundation is a leading European cancer center that specializes in the treatment of rare cancers and complex tumors. Gustave Roussy Foundation is located in Villejuif and Chevilly-Larue, France, and has 3,200 health professionals and 4,100 professionals working on its two campuses. The institute provides expert care for all cancers at every stage of life and caters to almost 50,000 patients per year. It is a source of diagnostic and therapeutic advances and integrates research, patient care, and teaching. The institute offers personalized management that combines innovation and a human-focused approach, taking into account care and physical, psychological, and social quality of life. | Hospital/Nursing Management | Director/Board Member | |
MEDINCELL S.A. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Chairman | |
KEDGE Business School | College/University | Undergraduate Degree | |
Atlanpole Biotherapies
Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman | |
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Medical/Nursing Services | Director/Board Member | |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member | |
Fondation A.R.CA.D. | Investment Trusts/Mutual Funds | Director/Board Member | |
Alain Oncologie Consulting
Alain Oncologie Consulting Miscellaneous Commercial ServicesCommercial Services Alain Oncologie Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ad Bio Consulting
Ad Bio Consulting Miscellaneous Commercial ServicesCommercial Services Ad Bio Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharmaengine Europe SARL
Pharmaengine Europe SARL Pharmaceuticals: MajorHealth Technology Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Pharmaceuticals: Major | Chief Executive Officer | |
Impulse Consulting Ltd. | Director/Board Member | ||
Mitrychem SAS | Corporate Officer/Principal | ||
Gustave Roussy Transfert
Gustave Roussy Transfert Miscellaneous Commercial ServicesCommercial Services Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care. | Miscellaneous Commercial Services | Director/Board Member | |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services The Society for Immunotherapy of Cancer (SITC) is an organization that advances the science, development, and application of immunotherapy to improve cancer patient outcomes. The non-profit company is based in Milwaukee, WI. SITC conducts policy and advocacy efforts on behalf of its members and the field. The Journal for Immunotherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of SITC, featuring original research articles, literature reviews, position papers, and discussions on all aspects of tumor immunology and cancer immunotherapy. SITC also created a conceptual framework for potential value in phase III studies evaluating immunotherapy combinations. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EMERCell SAS
EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed. | Pharmaceuticals: Major | Director/Board Member | |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Biotechnology | Founder | |
GLOBAL BIOENERGIES | Chemicals: Specialty | Director/Board Member Director/Board Member |
Estadísticas
Internacional
Francia | 34 |
Estados Unidos | 9 |
Reino Unido | 3 |
Países Bajos | 2 |
Argentina | 2 |
Sectorial
Consumer Services | 15 |
Health Technology | 14 |
Commercial Services | 11 |
Health Services | 4 |
Finance | 3 |
Operativa
Director/Board Member | 124 |
Corporate Officer/Principal | 83 |
Chairman | 20 |
Independent Dir/Board Member | 20 |
Undergraduate Degree | 19 |
Las relaciones más conectadas
Insiders | |
---|---|
Agnès Tixier | 24 |
Karine Lignel | 24 |
Patrick J. Langlois | 23 |
Anne-Marie Graffin | 22 |
Gary Phillips | 20 |
Alain Herrera | 17 |
Sébastien Groyer | 15 |
Jérôme Snollaerts | 15 |
Guy Rigaud | 14 |
Christophe Douat | 13 |
Enno Spillner | 13 |
Laurent Condomine | 11 |
Anne-Juliette Hermant | 9 |
Noël Kurdi | 9 |
Louis Kayitalire | 8 |
- Bolsa de valores
- Insiders
- Laurent Lévy
- Conexiones Empresas